Company intelligence / Profile preview

Cryoalfa

Radebeul, Saxony, Germany

Ownership: Private
Development stage: Other

Overview

Cryoalfa Europe is a German medical device company commercializing Cryoalfa cryosurgical instruments used to remove common benign skin lesions. Its handheld devices use nitrous oxide for liquid freezing and contact freezing, and are marketed for dermatology, aesthetic medicine, veterinary medicine, cosmetics, chiropody, and auriculotherapy applications. The company sells multiple device configurations, including SUPER, LUX, and PERFECT systems, along with consumable gas cartridges and applicators. Cryoalfa Europe appears to function as the commercial and operating entity for the Cryoalfa brand in Europe, while related patents and trademark ownership are associated with Cryoswiss GmbH in Switzerland.

Therapeutic areas: OtherDermatologyHematology
Modalities: DeviceNon-pharmacological therapy
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Cryoalfa.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cryoalfa.

Explore the full profile